ROKIT Healthcare Subsidiary ROKIT AMERICA Pursues Nasdaq Listing: $25M Public Offering

ROKIT Healthcare subsidiary ROKIT AMERICA, Inc. filed an amended Form S-1 to pursue listing on Nasdaq Global Market
Offering size: 2,631,579 new shares at expected price of $9.50 per share, raising $25 million
Over-allotment option (45 days) allows up to 394,737 additional shares, total up to $28.75 million
Underwriter Maxim Group LLC will purchase all offered shares on a firm commitment basis
Expected post-offering market cap approx. $262.5 million (KRW 380 billion) based on 27,631,679 total shares
Purpose: expand long-term regeneration platform (ORP) and reverse-aging business in Americas, secure independent funding
ROKIT Healthcare holds 100% of pre-offering shares; dilution expected post-listing
Shares issued via electronic registration; restricted from acquisition by Korean residents for a period
Final listing subject to SEC and Nasdaq approval, final offering price determination; listing date not yet set

Filing: [Correction of Description] Decision on Listing of Overseas Securities Market Stocks etc. (Major Management Matters of Subsidiary)
Company: ROKIT HEALTHCARE (376900)
Submission: ROKIT HEALTHCARE Inc.
Receipt: 05-11-2026
Under KRX KOSDAQ Market Division